[go: up one dir, main page]

GB202306711D0 - Novel proteins - Google Patents

Novel proteins

Info

Publication number
GB202306711D0
GB202306711D0 GBGB2306711.9A GB202306711A GB202306711D0 GB 202306711 D0 GB202306711 D0 GB 202306711D0 GB 202306711 A GB202306711 A GB 202306711A GB 202306711 D0 GB202306711 D0 GB 202306711D0
Authority
GB
United Kingdom
Prior art keywords
novel proteins
proteins
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2306711.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ducentis Biotherapeutics Ltd
Original Assignee
Ducentis Biotherapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ducentis Biotherapeutics Ltd filed Critical Ducentis Biotherapeutics Ltd
Priority to GBGB2306711.9A priority Critical patent/GB202306711D0/en
Publication of GB202306711D0 publication Critical patent/GB202306711D0/en
Priority to PCT/IB2024/054338 priority patent/WO2024231809A1/en
Priority to AU2024267726A priority patent/AU2024267726A1/en
Priority to KR1020257040907A priority patent/KR20260007620A/en
Priority to IL324093A priority patent/IL324093A/en
Priority to MX2025013204A priority patent/MX2025013204A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dermatology (AREA)
GBGB2306711.9A 2023-05-05 2023-05-05 Novel proteins Ceased GB202306711D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB2306711.9A GB202306711D0 (en) 2023-05-05 2023-05-05 Novel proteins
PCT/IB2024/054338 WO2024231809A1 (en) 2023-05-05 2024-05-03 Cd200 fusion proteins
AU2024267726A AU2024267726A1 (en) 2023-05-05 2024-05-03 Cd200 fusion proteins
KR1020257040907A KR20260007620A (en) 2023-05-05 2024-05-03 CD200 fusion protein
IL324093A IL324093A (en) 2023-05-05 2025-10-20 CD200 fusion proteins
MX2025013204A MX2025013204A (en) 2023-05-05 2025-11-04 Cd200 fusion proteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2306711.9A GB202306711D0 (en) 2023-05-05 2023-05-05 Novel proteins

Publications (1)

Publication Number Publication Date
GB202306711D0 true GB202306711D0 (en) 2023-06-21

Family

ID=86763284

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2306711.9A Ceased GB202306711D0 (en) 2023-05-05 2023-05-05 Novel proteins

Country Status (6)

Country Link
KR (1) KR20260007620A (en)
AU (1) AU2024267726A1 (en)
GB (1) GB202306711D0 (en)
IL (1) IL324093A (en)
MX (1) MX2025013204A (en)
WO (1) WO2024231809A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000078I2 (en) 1991-06-27 2011-01-13 Bristol Myers Squibb Co CTL4A receptor, fusion proteins containing it and their use
US5637481A (en) 1993-02-01 1997-06-10 Bristol-Myers Squibb Company Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
MXPA01010480A (en) 1999-04-13 2002-03-27 Schering Corp Novel uses of mammalian ox2 protein and related reagents.
CN101687033A (en) 2007-01-11 2010-03-31 贝林格尔.英格海姆国际有限公司 Cd200 and its receptor, cd200r, modulate bone mass via the differentiation of osteoclasts
JP6621478B2 (en) * 2014-12-19 2019-12-18 アルカーメス，インコーポレイテッド Single chain Fc fusion protein
GB201608197D0 (en) * 2016-05-10 2016-06-22 Ducentis Biotherapeutics Ltd Novel proteins
GB202115803D0 (en) * 2021-11-03 2021-12-15 Ducentis Biotherapeutics Ltd Novel proteins

Also Published As

Publication number Publication date
KR20260007620A (en) 2026-01-14
AU2024267726A1 (en) 2025-11-13
WO2024231809A1 (en) 2024-11-14
IL324093A (en) 2025-12-01
MX2025013204A (en) 2025-12-01

Similar Documents

Publication Publication Date Title
IL317214A (en) Novel polypeptides
IL312556A (en) Novel peptides
GB202115803D0 (en) Novel proteins
GB2635982B (en) Improved fluorescent proteins
GB202306711D0 (en) Novel proteins
GB202312969D0 (en) Modified proteins
GB202017506D0 (en) Novel proteins
GB202301919D0 (en) Protein
GB202301933D0 (en) Protein
GB202201715D0 (en) Protein
GB202201714D0 (en) Protein
IL324593A (en) Compact proteins
HK40115049A (en) Novel proteins
GB202212801D0 (en) Novel peptides
GB202204539D0 (en) Novel peptides
GB202210173D0 (en) Improved fluorescent proteins
GB202101825D0 (en) Protein
GB202101826D0 (en) Protein
GB202101828D0 (en) Protein
GB202302043D0 (en) Binding proteins
GB201913320D0 (en) Novel proteins
CA3282687A1 (en) Cd40-binding proteins
GB202319967D0 (en) Heteromultimeric proteins
GB201904756D0 (en) Novel proteins
AU2024320547A1 (en) Modified proteins

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)